Revolution Peripheral Atherectomy System, Revolution Peripheral Atherectomy Guidewire— 510(k) K191419

Name: FDA 510(k) clearance K191419
Creator: U.S. Food and Drug Administration
Published: 2019-09-12

Substantially Equivalent

Rex Medical, L.P.

FDA 510(k) clearance K191419 for Revolution Peripheral Atherectomy System, Revolution Peripheral Atherectomy Guidewire, Substantially Equivalent on 2019-09-12. Applicant: Rex Medical, L.P.. Device class: 2.

Clearance details

Applicant: Rex Medical, L.P.
Product code: Code MCW
Device class: Class 2
Regulation: 21 CFR 870.4875
Advisory panel: Cardiovascular
Date received: 2019-05-28
Decision date: 2019-09-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Conshohocken, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MCW

view all

K260244 — Auryon Atherectomy System2026-04-10
K250723 — FreedomFlow Orbital Circumferential Atherectomy System (H6005/ 4Fr 3-Sphere Configuration)2025-04-25
K250385 — Turbo-Elite Laser Atherectomy Catheter2025-03-13
K242757 — Rotarex Atherectomy System2025-01-30
K242947 — FreedomFlow Orbital Circumferential Atherectomy System2024-11-05

More clearances from Rex Medical, L.P.

view all

K212351 — Revolution Peripheral Atherectomy System2021-12-15
K173389 — Rex Medical Aspiration Pump2018-01-30
K143405 — Option (TM) ELITE Vena Cava Filter 100cm System2015-04-16
K141617 — CLEANER ROTATIONAL THROMBECTOMY SYSTEM2014-11-14
K133243 — OPTION ELITE VENA CAVA FILTER SYSTEM2013-12-17

Adverse events under product code MCW

product code MCW

Death: 38
Injury: 1,386
Malfunction: 2,676
Other: 2
Total: 4,102

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.